| |
| |
|
| Insider
Information: |
Scodari Joseph C |
| Relationship: |
Director |
| City: |
New Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
59,468 |
|
|
Indirect Shares
|
2,845 |
|
|
| Direct
Value |
$2,775,561 |
|
|
|
Indirect Value
|
$418,443 |
|
|
| Total
Shares |
62,313 |
|
|
| Total
Value |
$3,194,004 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Johnson & Johnson |
JNJ |
Retired Exec Committee... |
2008-05-28 |
18,646 |
2008-04-30 |
2,845 |
Premium* |
|
|
Endo Health Solutions Inc |
ENDP |
Director |
2013-03-12 |
6,515 |
|
0 |
Premium* |
|
|
Covance Inc |
CVD |
Director |
2015-02-19 |
0 |
2008-08-12 |
0 |
Premium* |
|
|
Optinose Inc |
OPTN |
Director |
2021-05-10 |
31,230 |
2018-12-12 |
0 |
Premium* |
|
|
Acurx Pharmaceuticals, Inc. |
ACXP |
Director |
2021-06-24 |
3,077 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CVD |
Covance Inc |
Director |
• • – |
2013-05-20 |
4 |
D |
$75.96 |
$121,538 |
D/D |
(1,600) |
5,040 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
• • – |
2014-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,426 |
7,466 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
• • – |
2014-05-20 |
4 |
D |
$83.78 |
$126,083 |
D/D |
(1,505) |
7,466 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
• • – |
2014-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,505 |
8,971 |
0 |
- |
|
| CVD |
Covance Inc |
Director |
• • – |
2015-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,466) |
0 |
0 |
- |
|
| OPTN |
Optinose Inc |
Director |
– • – |
2018-12-12 |
4 |
B |
$7.89 |
$50,733 |
D/D |
6,430 |
6,430 |
2.39 |
- |
|
| OPTN |
Optinose Inc |
Director |
– • – |
2019-12-06 |
4 |
B |
$8.22 |
$50,142 |
D/D |
6,100 |
12,530 |
2.39 |
- |
|
| OPTN |
Optinose Inc |
Director |
– • – |
2020-03-06 |
4 |
B |
$5.53 |
$49,605 |
D/D |
8,700 |
21,230 |
2.39 |
% |
|
| OPTN |
Optinose Inc |
Director |
– • – |
2021-05-10 |
4 |
B |
$2.99 |
$29,900 |
D/D |
10,000 |
31,230 |
2.39 |
% |
|
| JNJ |
Johnson & Johnson |
Executive Committee MemberOffi |
• – – |
2005-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,390 |
|
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2008-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,118 |
|
- |
|
| ACXP |
Acurx Pharmaceuticals, In... |
Director |
– • – |
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,077 |
|
- |
|
| JNJ |
Johnson & Johnson |
Executive Committee MemberOffi |
• – – |
2005-03-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,239 |
|
- |
|
63 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
